KEVIN JOHNSON: Open Payments
NPI 1194745877 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 11 payments from 6 companies in 2025. Trend: 2023 $26 · 2024 $43 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $102 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Gilead Sciences, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Antares Pharma, Inc. | 1 | $19 |
Products named: APRETUDE, PIFELTRO, DOVATO, AZMIRO, XYOSTED, Ozempic, Wegovy.
Industry payments across TX — which companies pay providers there.
